Debt swap: Veea (NASDAQ: VEEA) issues preferred shares and long-term warrants
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Veea Inc. entered a Note Conversion Agreement with NLabs Inc., an affiliate of its CEO, to convert outstanding debt into equity and warrants. About $4,132,910.49 of principal and accrued interest under NLabs demand notes were exchanged for 41,329 shares of Series A-1 preferred stock and Common Warrants.
The Common Warrants allow NLabs to purchase up to 13,331,969 shares of common stock at $0.31 per share, first exercisable on January 1, 2027 and expiring on June 25, 2031. Each Series A-1 preferred share is initially convertible into 323 common shares, giving voting rights and dividend equivalence to common stock. The issuance was made as an unregistered transaction relying on the Section 3(a)(9) exemption from Securities Act registration.
Positive
- None.
Negative
- None.
Insights
Veea swaps insider debt for preferred equity and long-dated warrants.
Veea converted about $4.13M of demand note obligations owed to NLabs, an affiliate of its CEO, into Series A-1 preferred stock plus Common Warrants. This replaces a cash-repayable liability with equity-linked instruments held by an insider-related entity.
The transaction introduces significant potential common stock issuance through both preferred conversion and warrant exercise at $0.31 per share, first exercisable in 2027 and expiring in 2031. Actual dilution will depend on future conversion and exercise decisions by NLabs, while the company immediately removes the demand notes from its debt stack.
8-K Event Classification
4 items: 1.01, 3.02, 5.03, 9.01
4 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02
Unregistered Sales of Equity Securities
Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Debt converted: $4,132,910.49 principal and interest
Preferred shares issued: 41,329 Series A-1 shares
Warrant share amount: 13,331,969 common shares
+5 more
8 metrics
Debt converted
$4,132,910.49 principal and interest
Aggregate Demand Notes exchanged June 25, 2026
Preferred shares issued
41,329 Series A-1 shares
Issued to NLabs under Note Conversion Agreement
Warrant share amount
13,331,969 common shares
Maximum shares purchasable under Common Warrants
Warrant exercise price
$0.31 per share
Exercise price for Common Warrants
Preferred stated value
$100.00 per share
Initial stated value (Per Share Price) of Series A-1
Conversion ratio
323 common shares per preferred share
Series A-1 Preferred Stock conversion feature
Warrant exercisability window
Jan 1, 2027 to Jun 25, 2031
Common Warrant first exercise date and expiration
Securities Act exemption
Section 3(a)(9)
Exemption cited for unregistered issuance
Key Terms
Note Conversion Agreement, Series A-1 Preferred Stock, Common Warrants, Certificate of Designation, +2 more
6 terms
Note Conversion Agreement financial
"entered into a Note Conversion Agreement (the “Note Conversion Agreement”) with NLabs Inc."
Series A-1 Preferred Stock financial
"shares of Series A-1 preferred stock, par value $0.0001 per share, of the Company"
Series A-1 preferred stock is a specific class of company shares created in an early financing round that typically gives its holders priority over common shareholders for dividends and money if the company is sold or liquidates. Think of it as a special ticket with upfront privileges — often convertible into ordinary shares and sometimes carrying voting or protective rights — so investors use it to reduce risk and preserve control compared with ordinary stock.
Common Warrants financial
"warrants to purchase shares of common stock (the “Common Warrants”)"
A common warrant is a tradable instrument that gives its holder the right to buy a company’s common shares at a fixed price within a set time period, similar to a coupon that can be redeemed later to purchase stock. Investors care because exercising warrants can boost potential gains if the stock rises, but it can also dilute existing shareholders by increasing the number of shares outstanding, which can lower per-share value.
Certificate of Designation regulatory
"the Company filed a Certificate of Designation of Series A-1 Convertible Preferred Stock"
A certificate of designation is a formal document that spells out the specific rights and rules attached to a particular class or series of stock, usually preferred shares. Think of it as a rulebook or menu that lists dividend terms, liquidation priority, conversion or redemption rights and any special voting protections; investors use it to judge how much income, control or downside protection those shares will provide compared with other securities.
Section 3(a)(9) regulatory
"in reliance on the exemption afforded by Section 3(a)(9) of the Securities Act of 1933"
Section 3(a)(9) is a provision of U.S. securities law that exempts certain exchanges of an issuer’s own securities with its existing holders from the usual public registration rules, typically when the swap doesn’t involve a public offering or outside buyers. For investors, it matters because such exchanges can change who holds what, affect dilution and liquidity, and may occur with less public disclosure than a registered sale — think of it like swapping old coupons for new ones behind the scenes rather than selling them in a public marketplace.
emerging growth company regulatory
"Emerging growth company Item 1.01 Entry into a Material Definitive Agreement."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What did Veea Inc. (VEEA) announce in this 8-K filing?
Veea Inc. disclosed a Note Conversion Agreement with NLabs Inc. converting about $4,132,910.49 of debt and interest into Series A-1 preferred shares and Common Warrants, changing its capital structure and eliminating those demand note obligations.
How much NLabs debt did Veea convert and into what securities?
Veea converted $4,132,910.49 of principal and accrued interest under NLabs demand notes into 41,329 Series A-1 preferred shares and Common Warrants to purchase up to 13,331,969 common shares, aligning the creditor’s position with equity-linked instruments.
What are the key terms of Veea’s new Common Warrants issued to NLabs?
The Common Warrants let NLabs buy up to 13,331,969 Veea common shares at $0.31 per share. They become exercisable on January 1, 2027 and remain exercisable until June 25, 2031, creating long-dated potential equity issuance.
Was Veea’s issuance of preferred stock and warrants to NLabs registered with the SEC?
No. Veea states the Series A-1 preferred shares and Common Warrants issued to NLabs were unregistered, relying on the exemption in Section 3(a)(9) of the Securities Act and applicable state blue sky law exemptions, meaning resale generally requires registration or another exemption.
What rights do holders of Veea’s Series A-1 Preferred Stock receive?
Holders of Series A-1 Preferred Stock may vote with common stock on an as-converted basis and receive dividends economically equivalent to any declared on common shares. They also have conversion rights using the $100.00 stated value divided by $0.31 conversion price.